Healthcare provider profile · identity verified

Rizalina Leuterio, M.D.

Family Practice · ORLANDO, FL · NPI 1275579021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	173
Amlodipine Besylate	Amlodipine Besylate	580	156
Metoprolol Succinate	Metoprolol Succinate	376	97
Pantoprazole Sodium	Pantoprazole Sodium	354	92
Gabapentin	Gabapentin	345	79
Lisinopril	Lisinopril	326	101
Losartan Potassium	Losartan Potassium	293	91
Levothyroxine Sodium	Levothyroxine Sodium	272	79
Metformin Hcl	Metformin Hcl	220	58
Omeprazole	Omeprazole	212	57
Alendronate Sodium	Alendronate Sodium	186	52
Rosuvastatin Calcium	Rosuvastatin Calcium	183	57
Ezetimibe	Ezetimibe	156	39
Furosemide	Furosemide	141	39
Albuterol Sulfate Hfa	Albuterol Sulfate	138	47
Sertraline Hcl	Sertraline Hcl	132	30
Eliquis	Apixaban	131	35
Trazodone Hcl	Trazodone Hcl	129	47
Januvia	Sitagliptin Phosphate	118	29
Escitalopram Oxalate	Escitalopram Oxalate	109	36
Pravastatin Sodium	Pravastatin Sodium	108	35
Famotidine	Famotidine	107	34
Azithromycin	Azithromycin	105	81
Hydrochlorothiazide	Hydrochlorothiazide	104	32
Metoprolol Tartrate	Metoprolol Tartrate	100	30
Carvedilol	Carvedilol	98	21
Doxazosin Mesylate	Doxazosin Mesylate	93	21
Ozempic	Semaglutide	90	20
Glipizide	Glipizide	87	24
Clopidogrel	Clopidogrel Bisulfate	85	17
Invokana	Canagliflozin	83	16
Mounjaro	Tirzepatide	83	15
Prednisone	Prednisone	82	41
Simvastatin	Simvastatin	76	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	24
Lovastatin	Lovastatin	73	20
Montelukast Sodium	Montelukast Sodium	64	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	63	15
Potassium Chloride	Potassium Chloride	63	21
Tizanidine Hcl	Tizanidine Hcl	63	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	18
Methylprednisolone	Methylprednisolone	60	49
Duloxetine Hcl	Duloxetine Hcl	59	16
Fluticasone Propionate	Fluticasone Propionate	57	19
Chlorthalidone	Chlorthalidone	51	16
Meloxicam	Meloxicam	50	17
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	47	13
Ibuprofen	Ibuprofen	46	32
Hydroxyzine Hcl	Hydroxyzine Hcl	43	14
Metformin Hcl Er	Metformin Hcl	43	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	35
Tamsulosin Hcl	Tamsulosin Hcl	41	13
Fluoxetine Hcl	Fluoxetine Hcl	40	12
Buspirone Hcl	Buspirone Hcl	39	16
Doxycycline Hyclate	Doxycycline Hyclate	39	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	16
Ondansetron Odt	Ondansetron	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	11
Triamcinolone Acetonide	Triamcinolone Acetonide	34	13
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Finasteride	Finasteride	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	12
Fenofibrate	Fenofibrate	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Jardiance	Empagliflozin	29	13
Cephalexin	Cephalexin	27	24
Tramadol Hcl	Tramadol Hcl	27	14
Meclizine Hcl	Meclizine Hcl	26	suppressed
Fluocinonide	Fluocinonide	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Atenolol	Atenolol	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Sucralfate	Sucralfate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Carbamazepine	Carbamazepine	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Novolog	Insulin Aspart	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Topiramate	Topiramate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Ramipril	Ramipril	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	12
Memantine Hcl	Memantine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Primidone	Primidone	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Nystatin	Nystatin	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error